Hege Sagstuen Haugnes
Stillingsbeskrivelse
Jeg jobber som professor i onkologi i 50% stilling ved UiT, kombinert med 50% stilling som seksjonsoverlege i uro-onkologi ved Universitetssykehuset Nord-Norge
Anna Patrikidou,
Walter Cazzaniga,
Christoph Oing,
Daniel Berney,
Joao Lobo,
Joost Boormans
m.fl.:
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines
Martin Støyten,
Tore Knutsen,
Inger Thune,
Einar Stikbakke,
Tom Wilsgaard,
Anne Elise Eggen
m.fl.:
Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study
Sophie Dorothea Fosså,
Tor Åge Myklebust,
Marianne Brydøy,
Helene Francisca Stigter Negaard,
Olbjørn Klepp,
Alv A Dahl
m.fl.:
Post-treatment paternity in testicular cancer survivors: Do demographic variables matter?
Helene Francisca Stigter Negaard,
Hege Sagstuen Haugnes,
Sophie Dorothea Fosså,
Gunhild Maria Gjerset,
Elisabeth Edvardsen,
Karl-Otto Larsen
m.fl.:
Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular Cancer
Mikkel Bandak,
Susanne Rosthøj,
Gitte Lerche Aalborg,
Jakob Lauritsen,
Aleksander Giwercman,
Hege Sagstuen Haugnes
m.fl.:
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide study
Tore Knutsen,
Erling Johan Aarsæther,
Tom Wilsgaard,
Martin Støyten,
Einar Stikbakke,
Elin Richardsen
m.fl.:
Robotic assisted radical prostatectomy improves biochemical recurrence-free survival: The PROCA-life study
Endre Gabrielsen,
Tom Wilsgaard,
Hanne Frydenberg,
Trygve Lofterød,
Stig Manfred Dalen,
Elin Synnøve Mortensen
m.fl.:
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study
Anna K. Jansson,
Gabriella Cohn-Cedermark,
Helene Francisca Stigter Negaard,
Torgrim Tandstad,
Olof Ståhl,
Annika Hedlund
m.fl.:
High-dose chemotherapy in male germ cell cancer patients—a study by the SWENOTECA group
Hege Sagstuen Haugnes,
Håkon Kjæve,
Eivind Bjerkaas,
Ragnhild Hellesnes,
Line Veronika Hjelle,
Magnus Larsen
:
Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
Selina R. van den Oever,
Renée L. Mulder,
Kevin C. Oeffinger,
Jourik A. Gietema,
Roderick Skinner,
Louis S. Constine
m.fl.:
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Sophie Dorothea Fosså,
Lars Johan Bjerner,
Torgrim Tandstad,
Marianne Brydøy,
Alv A Dahl,
Ragnhild Veline Nome
m.fl.:
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Anna Thor,
Mette Pernille Myklebust,
Anna Grenabo Bergdahl,
Per-Olof Lundgren,
Viktor Skokic,
Bjarte Almås
m.fl.:
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Martin Støyten,
Tore Knutsen,
Einar Stikbakke,
Ingvild Agledahl,
Tom Wilsgaard,
Anne Elise Eggen
m.fl.:
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
Rune Sundset,
Hege Sagstuen Haugnes,
Alexander Perez,
Ola Engelsen,
Ida Fosseide,
Miguel Castillejo
m.fl.:
Behandling av kastrasjonsresistent metastatisk prostatakreft med [177Lu]PSMA-radioligand
Axel Gerdtsson,
Helene Francisca Stigter Negaard,
Bjarte Almås,
Anna Grenabo Bergdahl,
Gabriella Cohn-Cedermark,
Ingrid Glimelius
m.fl.:
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
Anna Thor,
Helene Francisca Stigter Negaard,
Anna Grenabo Bergdahl,
Bjarte Almås,
Signe Melsen Larsen,
Per-Olof Lundgren
m.fl.:
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Alv A Dahl,
Cecilie E. Kiserud,
Alexander Fosså,
Jakob Rasmussen Skalleberg
m.fl.:
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Axel Gerdtsson,
Gustav Torisson,
Anna Thor,
Anna Grenabo Bergdahl,
Bjarte Almås,
Ulf Håkansson
m.fl.:
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
Marie Grøn Sælen,
Line Veronika Hjelle,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
m.fl.:
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Ramesh Upreti,
Elia Mmbaga,
Hege Sagstuen Haugnes,
Cecilie E. Kiserud,
Ruby del Risco Kollerud
:
Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway
Line Veronika Hjelle,
Marie Grøn Sælen,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
m.fl.:
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Lene Thorsen,
Kerry S. Courneya,
Jostein Steene-Johannessen,
Jon Michael Gran,
Hege Sagstuen Haugnes,
Helene Francisca Stigter Negaard
m.fl.:
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Einar Stikbakke,
Tom Wilsgaard,
Hege Sagstuen Haugnes,
Mona Irene Pedersen,
Tore Knutsen,
Martin Støyten
m.fl.:
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Jan Oldenburg,
D.M. Berney,
C. Bokemeyer,
Miguel Angel Climent,
G. Daugaard,
Jourik A. Gietema
m.fl.:
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Sophie Dorothea Fosså,
Alv A Dahl,
Lene Thorsen,
Ragnhild Hellesnes,
Cecilie E. Kiserud,
Torgrim Tandstad
m.fl.:
Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Mette Pernille Myklebust,
Anna Thor,
Nina Benedikte Rosenlund,
Peder Gjengstø,
Åsa Karlsdottir,
Marianne Brydøy
m.fl.:
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Axel Gerdtsson,
Anna Thor,
Anna Bergdahl Grenabo,
Bjarte Almås,
Ulf Håkansson,
Magnus Törnblom
m.fl.:
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Anders W. Bjerring,
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Ragnhild Veline Nome,
Thomas Muri Stokke,
Kristina Haugaa
m.fl.:
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: A 30-year follow-up
Ragnhild Hellesnes,
Tor Åge Myklebust,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen,
Helene Francisca Stigter Negaard
m.fl.:
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Hege S. Haugnes,
Helene Francisca Stigter Negaard,
Hilde Jensvoll,
Tom Wilsgaard,
Torgrim Tandstad,
Arne Solberg
:
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
Einar Stikbakke,
Henrik Schirmer,
Tore Knutsen,
Martin Støyten,
Tom Wilsgaard,
Edward L. Giovannucci
m.fl.:
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
Ragnhild Hellesnes,
Tor Åge Myklebust,
Sophie Dorothea Fosså,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen
m.fl.:
Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
Synne-Kristin Hoffart Bøhn,
Hanne Cathrine Lie,
Kristin Valborg Reinertsen,
Sophie Dorothea Fosså,
Hege Sagstuen Haugnes,
Cecilie E. Kiserud
m.fl.:
Lifestyle among long-term survivors of cancers in young adulthood
Hanne Skjerven Bersvendsen,
Hege Sagstuen Haugnes,
Alv A Dahl,
Unn-Merete Fagerli,
Øystein Fluge,
Harald Holte
m.fl.:
Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
Axel Gerdtsson,
Ulf Håkansson,
Magnus Törnblom,
George Jancke,
Helene Francisca Stigter Negaard,
Ingrid Glimelius
m.fl.:
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Lene Thorsen,
Hege Sagstuen Haugnes,
Sophie Dorothea Fosså,
Marianne Brydøy,
Torgrim Tandstad,
Torbjørn Wisløff
m.fl.:
Thromboembolic events after high-intensity training duringcisplatin-based chemotherapy for testicular cancer: Casereports and review of the literature
Ruby Del Risco Kollerud,
Hege Sagstuen Haugnes,
Bjørgulf Claussen,
Magne Thoresen,
Per Nafstad,
James Farnham
m.fl.:
A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USA.
Sophie Dorothea Fosså,
Alv A Dahl,
Tor Åge Myklebust,
Cecilie E. Kiserud,
Ragnhild Veline Nome,
Olbjørn Klepp
m.fl.:
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Ruby Del Risco Kollerud,
LA Cannon-Albright,
Hege Sagstuen Haugnes,
Ellen Ruud,
Magne Thoresen,
Per Nafstad
m.fl.:
Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.
Synne-Kristin Hoffart Bøhn,
Lene Thorsen,
Cecilie E. Kiserud,
Sophie Dorothea Fosså,
Hanne Cathrine Lie,
Jon Håvard Loge
m.fl.:
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Martin Støyten,
Hege Sagstuen Haugnes
:
Obesity, cardiac function and cardiovascular disease in prostate cancer
UiT Norges arktiske universitet 17. november 2026 ARKIV
Ingerid Skjei Knudtsen,
Bendik Skarre Abrahamsen,
Kirsten Margrete Selnæs,
Mattijs Elschot,
Andreas Julius Tulipan,
Eivor Hernes
m.fl.:
[68Ga]Ga-PSMA-11 vs [18F]F-PSMA-1007 PET/MRI of recurrent prostate cancer: detection rates at different PSA-levels and implications for salvage radiotherapy
18. juni 2025 ARKIV
Hege Sagstuen Haugnes,
T.Å. Myklebust,
Marianne Brydøy,
H. Negaard,
Eline Bragedatter Seljeflot,
Camilla Rørslett Kleveland
m.fl.:
1053P Post-diagnosis (post-TC) paternity in testicular cancer survivors (TCSs): A controlled cohort study
Sven Löffeler,
Helena Maria Bertilsson,
Christoph Rainer Müller,
Kirsti Aas,
Hege Sagstuen Haugnes,
Bjørg Yksnøy Aksnessæther
m.fl.:
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
Torgrim Tandstad,
Ragnhild Hellesnes,
Åsa Karlsdottir,
Øivind Kvammen,
Carl W. Langberg,
Helene Francisca Stigter Negaard
m.fl.:
Late relapse in testicular cancer: A report from a national cohort. Oral presentation
2022 ARKIV
Ingerid Skjei Knudtsen,
Bendik Skarre Abrahamsen,
Kirsten Margrete Selnæs,
Mattijs Elschot,
Sverre Langørgen,
Thomas Keil
m.fl.:
PSMA-PET-avbildning før primærbehandling av pasienter med høyrisiko prostatakreft
2022 ARKIV
Torgrim Tandstad,
Ragnhild Hellesnes,
Hege Sagstuen Haugnes,
Åsa Karlsdottir,
Carl W. Langberg,
Helene Francisca Stigter Negaard
m.fl.:
Late relapses in testicular cancer: Results from a national cohort
Hege Sagstuen Haugnes
:
Presentasjon av kreft seneffekt poliklinikken ved UNN
2022 ARKIV
Hege Sagstuen Haugnes
:
Presentasjon av seneffekt poliklinikken ved UNN
2022 ARKIV
B. Jordan,
A. Margulies,
F. Cardoso,
G. Cavaletti,
Hege Sagstuen Haugnes,
P. Jahn
m.fl.:
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
De 50 siste resultatene vises på siden. Se alle arbeider i NVA her →
Forskningsinteresser
Jeg er opptatt av forskning med fokus på 1) seneffekter etter kreftbehandling, 2) diagnostikk, behandling og oppfølging innen urologisk kreft (med fokus på testikkelkreft og prostatakreft) og 3) kliniske kreftforskningsprosjekter knyttet til Tromsøundersøkelsen (prostatakreft og brystkreft).
Undervisning
Jeg har mange års erfaring med å undervise i onkologi ved medisinstudiet, og er hovedansvarlig for delemne 6.4F ved campus Hammerfest.